Market revenue in 2023 | USD 155.4 million |
Market revenue in 2030 | USD 358.1 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.5% in 2023. Horizon Databook has segmented the North America mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
North American miRNA sequencing and assay market will be collectively driven by the presence of key players and an increase in their extensive R&D activities for novel diseases. Companies present in this region are involved in new product development to expand their product portfolios.
For instance, in October 2019, TriLink BioTechnologies, part of Maravai Life Sciences, launched two primer sets for its CleanTag kit. These newly launched lon Torrent barcode primer sets facilitate small RNA library preparation on the Thermo Fisher Scientific sequencer platform.
In addition, miRNA sequencing and assay are significantly adopted by clinics, healthcare networks, military, and agriculture laboratories, which receive support through government funding. Thus, supportive government laws and investments are contributing to regional market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America mirna sequencing and assay market , including forecasts for subscribers. This continent databook contains high-level insights into North America mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account